Personal Care Market Intelligence

  Preclinical CRO  Industry Overview The global preclinical CRO market size was valued at USD 4.87 billion in 2021 and is expected to advance at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030. Increased R&D budget for drug development is leading to rising demand for preclinical contract research organization (CRO) services, thus boosting the market growth during the forecast period. The surge in the number of preclinical trials involving large molecules and the growing need to curb R&D expense is expected to contribute to the growing demand for quality preclinical CRO. The ongoing COVID-19 pandemic initially disrupted preclinical research projects, especially during the first quarter of 2020. Nevertheless, lifesaving drugs are developing and are brought to market swiftly.   Gather more insights about the market drivers, restrains and growth of the Global Preclinical CRO Market   Over the years, there has been a significant change ...

  Healthcare Contract Research Organization  Industry Overview The global healthcare contract research organization market size was valued at USD 42.3 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.5% from 2022 to 2030. The increasing investment in R&D programs, preference for outsourcing activities due to time and cost constraints, and patent expiration in the healthcare sector are key factors anticipated to drive the market in the coming years. Contract research outsourcing collaborations offer cutting-edge services and thus government organizations prefer assigning projects to CROs, thereby facilitating the market growth.   Gather more insights about the market drivers, restrains and growth of the Global Healthcare Contract Research Organization Market   Increasing pressure on drug developers pertaining to clinical data management, regulatory environments, and stringent safety standards are the factors ex...

  Drug Discovery Outsourcing  Industry Overview The global drug discovery outsourcing market size was valued at USD 3.3 billion in 2021 and is anticipated to grow at a compound annual growth rate CAGR of 7.4% over the forecast period. According to a survey conducted by Life Science Strategy Group of 120 clinical development decision-makers in the U. S., Europe, and China, industry professionals are undertaking major strategic changes to maintain their share in the unpredictable market scenario post the COVID-19 pandemic. The pharmaceutical industry has witnessed radical changes in the past two decades, in terms of a shift toward biologics, patent expiration, and unprecedented downsizing of internal discovery of big pharmaceuticals. All of this has accelerated the adoption of outsourcing activities.   Gather more insights about the market drivers, restrains and growth of the Global Drug Discovery Outsourcing Market   Breaking down the different steps...

  Animal Health  Industry Overview The global animal health market size was valued at USD 39.9 billion in 2021 and is expected to witness a compound annual growth rate (CAGR) of 10.0% from 2022 to 2030. The market is largely driven by a significant rise in demand for protein food and an increase in the incidence of zoonotic and food-borne diseases globally. This unprecedented rise in disease prevalence has triggered companies to produce advanced vaccines and pharmaceuticals. The high demand has also resulted in a subsequent increase in the number of companies undertaking consistent efforts to control pathogen contamination risks and food-borne diseases, which is contributing to market growth. In addition, the rising number of government initiatives to promote animal health products is presumed to drive the overall market.   Gather more insights about the market drivers, restrains and growth of the Global Animal Health Market   In spite of disruption due ...

  Digital Health  Industry Overview The global digital health market size was valued at USD 175.6 billion in 2021 is projected to grow at a compound annual growth rate (CAGR) of 27.7% from 2022 to 2030. Increasing smartphone penetration, improving internet connectivity, advancing healthcare IT infrastructure, growing healthcare expenditure, rising prevalence of chronic diseases, increasing demand for remote patient monitoring services, and increasing accessibility of virtual care are driving market growth.      Gather more insights about the market drivers, restrains and growth of the Global Digital Health Market   Smartphones have broadened their scope from devices of communication & entertainment to devices monitoring health & fitness. As per a Pew Research Center in 2021, 97.0% of U.S. citizens own smartphones. Market players are developing innovative mobile applications to track daily activities such as fitness, exercise, nutrition,...

  Facial Injectable Industry Overview The global facial injectable market size was valued at USD 16.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% from 2022 to 2030. A growing focus on physical appearance among consumers has led to an increased demand for facial injectables in recent years. Increasing awareness regarding minimally invasive procedures due to various beauty campaigns being organized by key players in the market is also a driving factor for market growth. The ongoing COVID-19 pandemic has increased the time spent on video calls. Known as the ‘Zoom Boom’, several adults are becoming more aware of their appearance. This has increased demand for cosmetic surgeries, with Botox being one of the most popular products preferred. Gather more insights about the market drivers, restrains and growth of the Global Facial Injectable Market Patients are also opting for cosmetic surgeries owing to ease of recovery while staying at h...

  U.S. Revenue Cycle Management Industry Overview The U.S. revenue cycle management market size was valued at USD 126.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.3% from 2022 to 2030. The rapidly transforming healthcare system and adoption of digitalization are paving a path for implementing healthcare IT services such as revenue cycle management (RCM) systems to organize and streamline workflows of healthcare organizations using synchronized management software solutions. RCM solutions are an integration of payment models, reimbursement guidelines, codes, and third-party payers. Medical services are facing complex challenges in billing and precise payment, which is anticipated to drive the demand for innovative RCM solutions. The availability of advanced innovative RCM solutions offered by renowned third-party service providers enables the healthcare industry to leverage the economic value and efficacy of these RCM solution...